Immediate Impact
1 standout
Citing Papers
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
2019 Standout
Works of Beth-Ann Norton being referenced
Sa1198 Initial Vedolizumab Cohort: Patient Characteristics and Clinical Response
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Beth-Ann Norton | 5 | 7 | 2 | 4 | 9 | |
| Richard Shenderey | 6 | 7 | 1 | 2 | 8 | |
| E Domènech | 6 | 6 | 3 | 5 | 8 | |
| Waqas Gaba | 8 | 9 | 4 | 2 | 10 | |
| Lorena Forcelledo Espina | 5 | 5 | 4 | 10 | ||
| A Nucit | 3 | 4 | 3 | 4 | 8 | |
| Jordi Almirall Pujol | 7 | 5 | 2 | 9 | ||
| Neil R. Robertson | 3 | 4 | 1 | 4 | 10 | |
| Saagar Patel | 12 | 11 | 4 | 4 | 14 | |
| Nabeel Qureshi | 4 | 4 | 5 | 3 | 8 | |
| Sebanti Sengupta | 2 | 4 | 2 | 9 |
All Works
Loading papers...